About Us
DELFI Diagnostics Inc. (DELFI Diagnostics) is developing nextgeneration bloodbased tests that are reliable accessible and deliver a new way to help detect cancer. Employing advanced machinelearning methods to wholegenome sequencing data the DELFI (DNA EvaLuation of Fragments for early Interception) platform is built to address the highestburden health challenges. DELFI Diagnostics prioritizes solutions that have the potential to save lives on a global scale including for historically underserved populations. DELFI Diagnostics platform relies on fragmentomics the discovery that cancer cells are more chaotic than normal cells and when they die leave behind telltale patterns and characteristics of cellfree DNA (cfDNA) fragments. FirstLook Lung for individuals eligible for lung cancer screening is DELFI Diagnostics first laboratorydeveloped screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through lowdose CT including early stage disease with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA.
In our passionate pursuit to radically improve health outcomes we serve humanity when we:
Lead with Science Anchor in Pragmatism: We pioneer lifechanging science by ensuring quality transparency and rigor at all times. We explore thoughtfully experiment smartly and deliver impact with conviction.
Build With & For All: We embrace diverse backgrounds to innovate and achieve together. We are not just building a product we aim to disrupt the path of cancer for all no matter geography or socioeconomic class
Put We over I: We are a home for highperforming people. Through teamwork we build collective intelligence. Each of us wins when those we serve and those who serve with uswin. We show up with empathy humility and integrity at every step of the journey.
DELFI has 12 designated inoffice working days each week for employees who live within within 50 miles of Palo Alto CA or Baltimore MD offices
This role is responsible for leading a technical team focused on developing and validating computational algorithms for cancer detection using bloodbased omics data. You will lead crossfunctional collaboration with assay development teams clinical data scientists and software engineers to successfully transition cuttingedge research models into production environments. This position requires a unique blend of technical leadership scientific expertise and collaborative skills to advance cancer detection technologies from research concepts to practical applications.
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race religion color national origin gender sexual orientation age marital status veteran status or disability status.
This position is not eligible for agency partnership. Resumes and outreach from staffing representatives will be declined.